nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A5—Rosuvastatin—atherosclerosis	0.0809	0.124	CbGbCtD
Rivaroxaban—CYP3A5—Simvastatin—atherosclerosis	0.0752	0.116	CbGbCtD
Rivaroxaban—CYP3A5—Pravastatin—atherosclerosis	0.0736	0.113	CbGbCtD
Rivaroxaban—CYP3A5—Lovastatin—atherosclerosis	0.0736	0.113	CbGbCtD
Rivaroxaban—ABCB1—Ezetimibe—atherosclerosis	0.0527	0.0809	CbGbCtD
Rivaroxaban—ABCB1—Simvastatin—atherosclerosis	0.049	0.0752	CbGbCtD
Rivaroxaban—ABCB1—Lovastatin—atherosclerosis	0.0479	0.0736	CbGbCtD
Rivaroxaban—ABCB1—Pravastatin—atherosclerosis	0.0479	0.0736	CbGbCtD
Rivaroxaban—CYP3A4—Ezetimibe—atherosclerosis	0.0316	0.0485	CbGbCtD
Rivaroxaban—CYP3A4—Rosuvastatin—atherosclerosis	0.0316	0.0485	CbGbCtD
Rivaroxaban—CYP3A4—Simvastatin—atherosclerosis	0.0293	0.0451	CbGbCtD
Rivaroxaban—CYP3A4—Lovastatin—atherosclerosis	0.0287	0.0441	CbGbCtD
Rivaroxaban—CYP3A4—Pravastatin—atherosclerosis	0.0287	0.0441	CbGbCtD
Rivaroxaban—CYP2J2—artery—atherosclerosis	0.00321	0.253	CbGeAlD
Rivaroxaban—CYP2J2—blood vessel—atherosclerosis	0.0025	0.197	CbGeAlD
Rivaroxaban—Gamma-glutamyltransferase increased—Ezetimibe—atherosclerosis	0.00215	0.0144	CcSEcCtD
Rivaroxaban—Haemoptysis—Niacin—atherosclerosis	0.00209	0.014	CcSEcCtD
Rivaroxaban—Cholestasis—Niacin—atherosclerosis	0.00204	0.0136	CcSEcCtD
Rivaroxaban—Gamma-glutamyltransferase increased—Pravastatin—atherosclerosis	0.00185	0.0124	CcSEcCtD
Rivaroxaban—Renal failure acute—Rosuvastatin—atherosclerosis	0.00167	0.0112	CcSEcCtD
Rivaroxaban—Hepatic function abnormal—Lovastatin—atherosclerosis	0.0015	0.01	CcSEcCtD
Rivaroxaban—Hepatic function abnormal—Simvastatin—atherosclerosis	0.0014	0.00937	CcSEcCtD
Rivaroxaban—Swelling—Simvastatin—atherosclerosis	0.00139	0.00928	CcSEcCtD
Rivaroxaban—F10—cardiovascular system—atherosclerosis	0.00136	0.107	CbGeAlD
Rivaroxaban—Pain in extremity—Lovastatin—atherosclerosis	0.00131	0.00875	CcSEcCtD
Rivaroxaban—Hepatic function abnormal—Niacin—atherosclerosis	0.00129	0.0086	CcSEcCtD
Rivaroxaban—Pain in extremity—Ezetimibe—atherosclerosis	0.00128	0.00858	CcSEcCtD
Rivaroxaban—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00127	0.00847	CcSEcCtD
Rivaroxaban—F10—adipose tissue—atherosclerosis	0.0012	0.0947	CbGeAlD
Rivaroxaban—Renal failure acute—Pravastatin—atherosclerosis	0.0012	0.00802	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Niacin—atherosclerosis	0.00118	0.00786	CcSEcCtD
Rivaroxaban—Jaundice—Rosuvastatin—atherosclerosis	0.00116	0.00776	CcSEcCtD
Rivaroxaban—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00116	0.00774	CcSEcCtD
Rivaroxaban—Haematuria—Rosuvastatin—atherosclerosis	0.00113	0.00759	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00113	0.00753	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00112	0.00752	CcSEcCtD
Rivaroxaban—Sinusitis—Rosuvastatin—atherosclerosis	0.00112	0.00747	CcSEcCtD
Rivaroxaban—CYP2J2—cardiovascular system—atherosclerosis	0.00111	0.088	CbGeAlD
Rivaroxaban—Hepatitis—Rosuvastatin—atherosclerosis	0.00107	0.00714	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.001	0.00669	CcSEcCtD
Rivaroxaban—Infestation NOS—Ezetimibe—atherosclerosis	0.000989	0.00662	CcSEcCtD
Rivaroxaban—Infestation—Ezetimibe—atherosclerosis	0.000989	0.00662	CcSEcCtD
Rivaroxaban—Urinary tract infection—Lovastatin—atherosclerosis	0.00098	0.00656	CcSEcCtD
Rivaroxaban—Jaundice—Ezetimibe—atherosclerosis	0.000964	0.00645	CcSEcCtD
Rivaroxaban—Angina pectoris—Niacin—atherosclerosis	0.000946	0.00633	CcSEcCtD
Rivaroxaban—Sinusitis—Lovastatin—atherosclerosis	0.000946	0.00633	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000936	0.00626	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000935	0.00625	CcSEcCtD
Rivaroxaban—Angina pectoris—Pravastatin—atherosclerosis	0.000932	0.00623	CcSEcCtD
Rivaroxaban—Sinusitis—Ezetimibe—atherosclerosis	0.000928	0.00621	CcSEcCtD
Rivaroxaban—Jaundice—Simvastatin—atherosclerosis	0.00092	0.00615	CcSEcCtD
Rivaroxaban—Hepatitis—Lovastatin—atherosclerosis	0.000905	0.00605	CcSEcCtD
Rivaroxaban—Hepatitis—Ezetimibe—atherosclerosis	0.000888	0.00594	CcSEcCtD
Rivaroxaban—Sinusitis—Simvastatin—atherosclerosis	0.000885	0.00592	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000873	0.00584	CcSEcCtD
Rivaroxaban—Erythema multiforme—Lovastatin—atherosclerosis	0.000856	0.00572	CcSEcCtD
Rivaroxaban—Angioedema—Rosuvastatin—atherosclerosis	0.00085	0.00568	CcSEcCtD
Rivaroxaban—Hepatitis—Simvastatin—atherosclerosis	0.000847	0.00566	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000846	0.00565	CcSEcCtD
Rivaroxaban—Jaundice—Niacin—atherosclerosis	0.000844	0.00565	CcSEcCtD
Rivaroxaban—F10—liver—atherosclerosis	0.000841	0.0664	CbGeAlD
Rivaroxaban—Erythema multiforme—Ezetimibe—atherosclerosis	0.00084	0.00561	CcSEcCtD
Rivaroxaban—Jaundice—Pravastatin—atherosclerosis	0.000831	0.00556	CcSEcCtD
Rivaroxaban—Urinary tract infection—Pravastatin—atherosclerosis	0.000829	0.00554	CcSEcCtD
Rivaroxaban—Angiopathy—Ezetimibe—atherosclerosis	0.000806	0.00539	CcSEcCtD
Rivaroxaban—Immune system disorder—Ezetimibe—atherosclerosis	0.000802	0.00536	CcSEcCtD
Rivaroxaban—Erythema multiforme—Simvastatin—atherosclerosis	0.000801	0.00535	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Ezetimibe—atherosclerosis	0.0008	0.00535	CcSEcCtD
Rivaroxaban—Sinusitis—Pravastatin—atherosclerosis	0.0008	0.00535	CcSEcCtD
Rivaroxaban—Haemoglobin—Niacin—atherosclerosis	0.000782	0.00523	CcSEcCtD
Rivaroxaban—Haemorrhage—Niacin—atherosclerosis	0.000778	0.0052	CcSEcCtD
Rivaroxaban—Hepatitis—Niacin—atherosclerosis	0.000778	0.0052	CcSEcCtD
Rivaroxaban—Hepatitis—Pravastatin—atherosclerosis	0.000766	0.00512	CcSEcCtD
Rivaroxaban—Back pain—Lovastatin—atherosclerosis	0.000762	0.0051	CcSEcCtD
Rivaroxaban—Muscle spasms—Lovastatin—atherosclerosis	0.000758	0.00507	CcSEcCtD
Rivaroxaban—Infection—Rosuvastatin—atherosclerosis	0.000754	0.00504	CcSEcCtD
Rivaroxaban—Back pain—Ezetimibe—atherosclerosis	0.000748	0.005	CcSEcCtD
Rivaroxaban—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000744	0.00498	CcSEcCtD
Rivaroxaban—Muscle spasms—Ezetimibe—atherosclerosis	0.000743	0.00497	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Lovastatin—atherosclerosis	0.000731	0.00489	CcSEcCtD
Rivaroxaban—Eye disorder—Niacin—atherosclerosis	0.000727	0.00486	CcSEcCtD
Rivaroxaban—Erythema multiforme—Pravastatin—atherosclerosis	0.000724	0.00484	CcSEcCtD
Rivaroxaban—Angioedema—Lovastatin—atherosclerosis	0.00072	0.00482	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000717	0.0048	CcSEcCtD
Rivaroxaban—Anaemia—Ezetimibe—atherosclerosis	0.000715	0.00478	CcSEcCtD
Rivaroxaban—Malaise—Lovastatin—atherosclerosis	0.000711	0.00475	CcSEcCtD
Rivaroxaban—Cardiac disorder—Pravastatin—atherosclerosis	0.000711	0.00475	CcSEcCtD
Rivaroxaban—Muscle spasms—Simvastatin—atherosclerosis	0.000709	0.00474	CcSEcCtD
Rivaroxaban—Angioedema—Ezetimibe—atherosclerosis	0.000706	0.00472	CcSEcCtD
Rivaroxaban—Angiopathy—Niacin—atherosclerosis	0.000706	0.00472	CcSEcCtD
Rivaroxaban—Malaise—Ezetimibe—atherosclerosis	0.000697	0.00466	CcSEcCtD
Rivaroxaban—CYP2J2—liver—atherosclerosis	0.000689	0.0544	CbGeAlD
Rivaroxaban—Ill-defined disorder—Simvastatin—atherosclerosis	0.000684	0.00457	CcSEcCtD
Rivaroxaban—Anaemia—Simvastatin—atherosclerosis	0.000681	0.00456	CcSEcCtD
Rivaroxaban—Angioedema—Simvastatin—atherosclerosis	0.000674	0.0045	CcSEcCtD
Rivaroxaban—Chest pain—Lovastatin—atherosclerosis	0.000671	0.00449	CcSEcCtD
Rivaroxaban—Dyspepsia—Rosuvastatin—atherosclerosis	0.000668	0.00447	CcSEcCtD
Rivaroxaban—Malaise—Simvastatin—atherosclerosis	0.000665	0.00445	CcSEcCtD
Rivaroxaban—Discomfort—Lovastatin—atherosclerosis	0.000663	0.00443	CcSEcCtD
Rivaroxaban—Chest pain—Ezetimibe—atherosclerosis	0.000658	0.0044	CcSEcCtD
Rivaroxaban—Dry mouth—Lovastatin—atherosclerosis	0.000656	0.00439	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000654	0.00437	CcSEcCtD
Rivaroxaban—Muscle spasms—Niacin—atherosclerosis	0.000651	0.00435	CcSEcCtD
Rivaroxaban—Discomfort—Ezetimibe—atherosclerosis	0.00065	0.00435	CcSEcCtD
Rivaroxaban—Pain—Rosuvastatin—atherosclerosis	0.000649	0.00434	CcSEcCtD
Rivaroxaban—Constipation—Rosuvastatin—atherosclerosis	0.000649	0.00434	CcSEcCtD
Rivaroxaban—Dry mouth—Ezetimibe—atherosclerosis	0.000644	0.0043	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Lovastatin—atherosclerosis	0.000643	0.0043	CcSEcCtD
Rivaroxaban—Muscle spasms—Pravastatin—atherosclerosis	0.000641	0.00429	CcSEcCtD
Rivaroxaban—Infection—Lovastatin—atherosclerosis	0.000639	0.00427	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000631	0.00422	CcSEcCtD
Rivaroxaban—Chest pain—Simvastatin—atherosclerosis	0.000628	0.0042	CcSEcCtD
Rivaroxaban—Infection—Ezetimibe—atherosclerosis	0.000627	0.00419	CcSEcCtD
Rivaroxaban—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000625	0.00418	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000621	0.00415	CcSEcCtD
Rivaroxaban—Discomfort—Simvastatin—atherosclerosis	0.00062	0.00415	CcSEcCtD
Rivaroxaban—Nervous system disorder—Ezetimibe—atherosclerosis	0.000619	0.00414	CcSEcCtD
Rivaroxaban—Angioedema—Niacin—atherosclerosis	0.000619	0.00414	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Pravastatin—atherosclerosis	0.000618	0.00414	CcSEcCtD
Rivaroxaban—Anaemia—Pravastatin—atherosclerosis	0.000616	0.00412	CcSEcCtD
Rivaroxaban—Skin disorder—Ezetimibe—atherosclerosis	0.000613	0.0041	CcSEcCtD
Rivaroxaban—Angioedema—Pravastatin—atherosclerosis	0.000609	0.00407	CcSEcCtD
Rivaroxaban—Syncope—Niacin—atherosclerosis	0.000607	0.00406	CcSEcCtD
Rivaroxaban—Urticaria—Rosuvastatin—atherosclerosis	0.000603	0.00403	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Simvastatin—atherosclerosis	0.000602	0.00402	CcSEcCtD
Rivaroxaban—Oedema—Simvastatin—atherosclerosis	0.000602	0.00402	CcSEcCtD
Rivaroxaban—Malaise—Pravastatin—atherosclerosis	0.000601	0.00402	CcSEcCtD
Rivaroxaban—Abdominal pain—Rosuvastatin—atherosclerosis	0.0006	0.00401	CcSEcCtD
Rivaroxaban—Infection—Simvastatin—atherosclerosis	0.000598	0.004	CcSEcCtD
Rivaroxaban—Loss of consciousness—Niacin—atherosclerosis	0.000595	0.00398	CcSEcCtD
Rivaroxaban—Dyspnoea—Lovastatin—atherosclerosis	0.000573	0.00383	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000572	0.00383	CcSEcCtD
Rivaroxaban—Chest pain—Pravastatin—atherosclerosis	0.000567	0.00379	CcSEcCtD
Rivaroxaban—Dyspepsia—Lovastatin—atherosclerosis	0.000566	0.00379	CcSEcCtD
Rivaroxaban—Dry mouth—Niacin—atherosclerosis	0.000564	0.00377	CcSEcCtD
Rivaroxaban—Dyspnoea—Ezetimibe—atherosclerosis	0.000562	0.00376	CcSEcCtD
Rivaroxaban—Discomfort—Pravastatin—atherosclerosis	0.000561	0.00375	CcSEcCtD
Rivaroxaban—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000559	0.00374	CcSEcCtD
Rivaroxaban—Dyspepsia—Ezetimibe—atherosclerosis	0.000555	0.00371	CcSEcCtD
Rivaroxaban—Fatigue—Lovastatin—atherosclerosis	0.000555	0.00371	CcSEcCtD
Rivaroxaban—Oedema—Niacin—atherosclerosis	0.000552	0.00369	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Niacin—atherosclerosis	0.000552	0.00369	CcSEcCtD
Rivaroxaban—Pain—Lovastatin—atherosclerosis	0.00055	0.00368	CcSEcCtD
Rivaroxaban—Constipation—Lovastatin—atherosclerosis	0.00055	0.00368	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000545	0.00364	CcSEcCtD
Rivaroxaban—Asthenia—Rosuvastatin—atherosclerosis	0.000545	0.00364	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Pravastatin—atherosclerosis	0.000544	0.00364	CcSEcCtD
Rivaroxaban—Oedema—Pravastatin—atherosclerosis	0.000544	0.00364	CcSEcCtD
Rivaroxaban—Fatigue—Ezetimibe—atherosclerosis	0.000544	0.00364	CcSEcCtD
Rivaroxaban—Shock—Niacin—atherosclerosis	0.000544	0.00363	CcSEcCtD
Rivaroxaban—Infection—Pravastatin—atherosclerosis	0.00054	0.00361	CcSEcCtD
Rivaroxaban—Pain—Ezetimibe—atherosclerosis	0.00054	0.00361	CcSEcCtD
Rivaroxaban—Constipation—Ezetimibe—atherosclerosis	0.00054	0.00361	CcSEcCtD
Rivaroxaban—Tachycardia—Niacin—atherosclerosis	0.000539	0.00361	CcSEcCtD
Rivaroxaban—Pruritus—Rosuvastatin—atherosclerosis	0.000537	0.00359	CcSEcCtD
Rivaroxaban—Skin disorder—Niacin—atherosclerosis	0.000537	0.00359	CcSEcCtD
Rivaroxaban—Dyspnoea—Simvastatin—atherosclerosis	0.000536	0.00359	CcSEcCtD
Rivaroxaban—Feeling abnormal—Lovastatin—atherosclerosis	0.00053	0.00354	CcSEcCtD
Rivaroxaban—Dyspepsia—Simvastatin—atherosclerosis	0.00053	0.00354	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000526	0.00352	CcSEcCtD
Rivaroxaban—Feeling abnormal—Ezetimibe—atherosclerosis	0.00052	0.00348	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000519	0.00347	CcSEcCtD
Rivaroxaban—Diarrhoea—Rosuvastatin—atherosclerosis	0.000519	0.00347	CcSEcCtD
Rivaroxaban—Fatigue—Simvastatin—atherosclerosis	0.000519	0.00347	CcSEcCtD
Rivaroxaban—Hypotension—Niacin—atherosclerosis	0.000516	0.00345	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000516	0.00345	CcSEcCtD
Rivaroxaban—Pain—Simvastatin—atherosclerosis	0.000515	0.00344	CcSEcCtD
Rivaroxaban—Constipation—Simvastatin—atherosclerosis	0.000515	0.00344	CcSEcCtD
Rivaroxaban—Urticaria—Lovastatin—atherosclerosis	0.000511	0.00342	CcSEcCtD
Rivaroxaban—Abdominal pain—Lovastatin—atherosclerosis	0.000509	0.0034	CcSEcCtD
Rivaroxaban—Dizziness—Rosuvastatin—atherosclerosis	0.000502	0.00336	CcSEcCtD
Rivaroxaban—Urticaria—Ezetimibe—atherosclerosis	0.000501	0.00335	CcSEcCtD
Rivaroxaban—Abdominal pain—Ezetimibe—atherosclerosis	0.000499	0.00334	CcSEcCtD
Rivaroxaban—Feeling abnormal—Simvastatin—atherosclerosis	0.000496	0.00332	CcSEcCtD
Rivaroxaban—Dyspnoea—Niacin—atherosclerosis	0.000493	0.00329	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000492	0.00329	CcSEcCtD
Rivaroxaban—Dyspepsia—Niacin—atherosclerosis	0.000486	0.00325	CcSEcCtD
Rivaroxaban—Dyspnoea—Pravastatin—atherosclerosis	0.000485	0.00324	CcSEcCtD
Rivaroxaban—Dyspepsia—Pravastatin—atherosclerosis	0.000479	0.0032	CcSEcCtD
Rivaroxaban—Rash—Rosuvastatin—atherosclerosis	0.000479	0.0032	CcSEcCtD
Rivaroxaban—Dermatitis—Rosuvastatin—atherosclerosis	0.000478	0.0032	CcSEcCtD
Rivaroxaban—Urticaria—Simvastatin—atherosclerosis	0.000478	0.0032	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Niacin—atherosclerosis	0.000477	0.00319	CcSEcCtD
Rivaroxaban—Abdominal pain—Simvastatin—atherosclerosis	0.000476	0.00318	CcSEcCtD
Rivaroxaban—Headache—Rosuvastatin—atherosclerosis	0.000476	0.00318	CcSEcCtD
Rivaroxaban—Hypersensitivity—Lovastatin—atherosclerosis	0.000474	0.00317	CcSEcCtD
Rivaroxaban—Pain—Niacin—atherosclerosis	0.000472	0.00316	CcSEcCtD
Rivaroxaban—Fatigue—Pravastatin—atherosclerosis	0.000469	0.00314	CcSEcCtD
Rivaroxaban—ABCB1—blood vessel—atherosclerosis	0.000467	0.0369	CbGeAlD
Rivaroxaban—Pain—Pravastatin—atherosclerosis	0.000465	0.00311	CcSEcCtD
Rivaroxaban—Constipation—Pravastatin—atherosclerosis	0.000465	0.00311	CcSEcCtD
Rivaroxaban—Hypersensitivity—Ezetimibe—atherosclerosis	0.000465	0.00311	CcSEcCtD
Rivaroxaban—Asthenia—Lovastatin—atherosclerosis	0.000462	0.00309	CcSEcCtD
Rivaroxaban—Pruritus—Lovastatin—atherosclerosis	0.000455	0.00304	CcSEcCtD
Rivaroxaban—Asthenia—Ezetimibe—atherosclerosis	0.000453	0.00303	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Niacin—atherosclerosis	0.000452	0.00302	CcSEcCtD
Rivaroxaban—Nausea—Rosuvastatin—atherosclerosis	0.000451	0.00301	CcSEcCtD
Rivaroxaban—Feeling abnormal—Pravastatin—atherosclerosis	0.000448	0.003	CcSEcCtD
Rivaroxaban—Pruritus—Ezetimibe—atherosclerosis	0.000446	0.00298	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000445	0.00297	CcSEcCtD
Rivaroxaban—Hypersensitivity—Simvastatin—atherosclerosis	0.000443	0.00296	CcSEcCtD
Rivaroxaban—Diarrhoea—Lovastatin—atherosclerosis	0.00044	0.00294	CcSEcCtD
Rivaroxaban—Urticaria—Niacin—atherosclerosis	0.000439	0.00293	CcSEcCtD
Rivaroxaban—Abdominal pain—Niacin—atherosclerosis	0.000437	0.00292	CcSEcCtD
Rivaroxaban—Urticaria—Pravastatin—atherosclerosis	0.000432	0.00289	CcSEcCtD
Rivaroxaban—Asthenia—Simvastatin—atherosclerosis	0.000432	0.00289	CcSEcCtD
Rivaroxaban—Diarrhoea—Ezetimibe—atherosclerosis	0.000432	0.00289	CcSEcCtD
Rivaroxaban—Abdominal pain—Pravastatin—atherosclerosis	0.00043	0.00288	CcSEcCtD
Rivaroxaban—Pruritus—Simvastatin—atherosclerosis	0.000426	0.00285	CcSEcCtD
Rivaroxaban—Dizziness—Lovastatin—atherosclerosis	0.000425	0.00284	CcSEcCtD
Rivaroxaban—Dizziness—Ezetimibe—atherosclerosis	0.000417	0.00279	CcSEcCtD
Rivaroxaban—Diarrhoea—Simvastatin—atherosclerosis	0.000412	0.00275	CcSEcCtD
Rivaroxaban—Vomiting—Lovastatin—atherosclerosis	0.000409	0.00273	CcSEcCtD
Rivaroxaban—Hypersensitivity—Niacin—atherosclerosis	0.000407	0.00272	CcSEcCtD
Rivaroxaban—Rash—Lovastatin—atherosclerosis	0.000406	0.00271	CcSEcCtD
Rivaroxaban—Dermatitis—Lovastatin—atherosclerosis	0.000405	0.00271	CcSEcCtD
Rivaroxaban—Headache—Lovastatin—atherosclerosis	0.000403	0.00269	CcSEcCtD
Rivaroxaban—Vomiting—Ezetimibe—atherosclerosis	0.000401	0.00268	CcSEcCtD
Rivaroxaban—Hypersensitivity—Pravastatin—atherosclerosis	0.000401	0.00268	CcSEcCtD
Rivaroxaban—Dizziness—Simvastatin—atherosclerosis	0.000398	0.00266	CcSEcCtD
Rivaroxaban—Rash—Ezetimibe—atherosclerosis	0.000398	0.00266	CcSEcCtD
Rivaroxaban—Dermatitis—Ezetimibe—atherosclerosis	0.000397	0.00266	CcSEcCtD
Rivaroxaban—Asthenia—Niacin—atherosclerosis	0.000396	0.00265	CcSEcCtD
Rivaroxaban—Headache—Ezetimibe—atherosclerosis	0.000395	0.00264	CcSEcCtD
Rivaroxaban—Pruritus—Niacin—atherosclerosis	0.000391	0.00261	CcSEcCtD
Rivaroxaban—Asthenia—Pravastatin—atherosclerosis	0.00039	0.00261	CcSEcCtD
Rivaroxaban—Pruritus—Pravastatin—atherosclerosis	0.000385	0.00257	CcSEcCtD
Rivaroxaban—Vomiting—Simvastatin—atherosclerosis	0.000383	0.00256	CcSEcCtD
Rivaroxaban—Nausea—Lovastatin—atherosclerosis	0.000382	0.00256	CcSEcCtD
Rivaroxaban—Rash—Simvastatin—atherosclerosis	0.000379	0.00254	CcSEcCtD
Rivaroxaban—Dermatitis—Simvastatin—atherosclerosis	0.000379	0.00253	CcSEcCtD
Rivaroxaban—Diarrhoea—Niacin—atherosclerosis	0.000378	0.00253	CcSEcCtD
Rivaroxaban—Headache—Simvastatin—atherosclerosis	0.000377	0.00252	CcSEcCtD
Rivaroxaban—Nausea—Ezetimibe—atherosclerosis	0.000375	0.00251	CcSEcCtD
Rivaroxaban—Diarrhoea—Pravastatin—atherosclerosis	0.000372	0.00249	CcSEcCtD
Rivaroxaban—Dizziness—Niacin—atherosclerosis	0.000365	0.00244	CcSEcCtD
Rivaroxaban—Dizziness—Pravastatin—atherosclerosis	0.00036	0.00241	CcSEcCtD
Rivaroxaban—Nausea—Simvastatin—atherosclerosis	0.000357	0.00239	CcSEcCtD
Rivaroxaban—Vomiting—Niacin—atherosclerosis	0.000351	0.00235	CcSEcCtD
Rivaroxaban—Rash—Niacin—atherosclerosis	0.000348	0.00233	CcSEcCtD
Rivaroxaban—Dermatitis—Niacin—atherosclerosis	0.000348	0.00233	CcSEcCtD
Rivaroxaban—Headache—Niacin—atherosclerosis	0.000346	0.00231	CcSEcCtD
Rivaroxaban—Vomiting—Pravastatin—atherosclerosis	0.000346	0.00231	CcSEcCtD
Rivaroxaban—CYP3A5—adipose tissue—atherosclerosis	0.000346	0.0273	CbGeAlD
Rivaroxaban—Rash—Pravastatin—atherosclerosis	0.000343	0.00229	CcSEcCtD
Rivaroxaban—Dermatitis—Pravastatin—atherosclerosis	0.000343	0.00229	CcSEcCtD
Rivaroxaban—Headache—Pravastatin—atherosclerosis	0.000341	0.00228	CcSEcCtD
Rivaroxaban—Nausea—Niacin—atherosclerosis	0.000328	0.00219	CcSEcCtD
Rivaroxaban—Nausea—Pravastatin—atherosclerosis	0.000323	0.00216	CcSEcCtD
Rivaroxaban—CYP3A5—liver—atherosclerosis	0.000243	0.0192	CbGeAlD
Rivaroxaban—ABCB1—cardiovascular system—atherosclerosis	0.000208	0.0164	CbGeAlD
Rivaroxaban—ABCB1—adipose tissue—atherosclerosis	0.000184	0.0145	CbGeAlD
Rivaroxaban—CYP3A4—liver—atherosclerosis	0.000182	0.0144	CbGeAlD
Rivaroxaban—ABCB1—liver—atherosclerosis	0.000129	0.0102	CbGeAlD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	9.77e-05	0.000522	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CAV1—atherosclerosis	9.71e-05	0.000519	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—APOA1—atherosclerosis	9.69e-05	0.000518	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—LPA—atherosclerosis	9.63e-05	0.000515	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	9.5e-05	0.000508	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—BGN—atherosclerosis	9.32e-05	0.000498	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	9.26e-05	0.000495	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—F2—atherosclerosis	9.24e-05	0.000494	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOA5—atherosclerosis	9.23e-05	0.000493	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—NOS2—atherosclerosis	9.13e-05	0.000488	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	9.02e-05	0.000482	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.97e-05	0.000479	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	8.9e-05	0.000476	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PLA2G1B—atherosclerosis	8.89e-05	0.000475	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PIK3CG—atherosclerosis	8.85e-05	0.000473	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	8.78e-05	0.00047	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	8.7e-05	0.000465	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	8.68e-05	0.000464	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALOX5—atherosclerosis	8.58e-05	0.000459	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	8.4e-05	0.000449	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	8.34e-05	0.000446	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	8.23e-05	0.00044	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IGF1—atherosclerosis	8.1e-05	0.000433	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—GSTM1—atherosclerosis	8.01e-05	0.000428	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—MMP1—atherosclerosis	7.97e-05	0.000426	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.93e-05	0.000424	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—GSTM1—atherosclerosis	7.9e-05	0.000422	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—AGT—atherosclerosis	7.87e-05	0.000421	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	7.78e-05	0.000416	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—LEP—atherosclerosis	7.71e-05	0.000412	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NAMPT—atherosclerosis	7.7e-05	0.000411	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—SERPINE1—atherosclerosis	7.69e-05	0.000411	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—ALB—atherosclerosis	7.68e-05	0.00041	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.65e-05	0.000409	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—LIPC—atherosclerosis	7.65e-05	0.000409	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOC3—atherosclerosis	7.6e-05	0.000406	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—LDLR—atherosclerosis	7.55e-05	0.000404	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	7.46e-05	0.000399	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CETP—atherosclerosis	7.38e-05	0.000394	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—NOS3—atherosclerosis	7.34e-05	0.000392	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—F2—atherosclerosis	7.27e-05	0.000389	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	7.2e-05	0.000385	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—SCARB1—atherosclerosis	7.07e-05	0.000378	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.88e-05	0.000368	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—HMGCR—atherosclerosis	6.67e-05	0.000357	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IFNG—atherosclerosis	6.63e-05	0.000354	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—INS—atherosclerosis	6.59e-05	0.000352	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CCL2—atherosclerosis	6.48e-05	0.000346	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—IGF1—atherosclerosis	6.37e-05	0.000341	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—MMP2—atherosclerosis	6.17e-05	0.00033	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	6.16e-05	0.000329	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.02e-05	0.000322	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ABCA1—atherosclerosis	5.95e-05	0.000318	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL1B—atherosclerosis	5.91e-05	0.000316	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	5.9e-05	0.000315	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	5.8e-05	0.00031	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	5.78e-05	0.000309	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LDLRAP1—atherosclerosis	5.68e-05	0.000304	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	5.35e-05	0.000286	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLTP—atherosclerosis	5.34e-05	0.000286	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—VEGFA—atherosclerosis	5.29e-05	0.000283	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	5.17e-05	0.000276	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CXCL8—atherosclerosis	5.12e-05	0.000274	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—HMOX1—atherosclerosis	5.1e-05	0.000273	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—MAPK3—atherosclerosis	5e-05	0.000267	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	5e-05	0.000267	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOB—atherosclerosis	4.89e-05	0.000261	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TGFB1—atherosclerosis	4.86e-05	0.00026	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	4.81e-05	0.000257	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTM1—atherosclerosis	4.76e-05	0.000254	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—LPL—atherosclerosis	4.67e-05	0.000249	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LTA4H—atherosclerosis	4.63e-05	0.000248	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCG8—atherosclerosis	4.63e-05	0.000248	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	4.63e-05	0.000247	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	4.59e-05	0.000245	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GPX1—atherosclerosis	4.55e-05	0.000243	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CD36—atherosclerosis	4.43e-05	0.000237	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	4.37e-05	0.000233	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TNF—atherosclerosis	4.29e-05	0.000229	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LDLRAP1—atherosclerosis	4.29e-05	0.000229	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—MTHFR—atherosclerosis	4.2e-05	0.000225	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARA—atherosclerosis	4.12e-05	0.00022	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLTP—atherosclerosis	4.03e-05	0.000215	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AGT—atherosclerosis	3.99e-05	0.000213	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOE—atherosclerosis	3.91e-05	0.000209	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CAV1—atherosclerosis	3.88e-05	0.000207	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOA1—atherosclerosis	3.87e-05	0.000207	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	3.78e-05	0.000202	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.73e-05	0.000199	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	3.69e-05	0.000197	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.67e-05	0.000196	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCG1—atherosclerosis	3.66e-05	0.000196	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CG—atherosclerosis	3.53e-05	0.000189	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCG8—atherosclerosis	3.5e-05	0.000187	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LTA4H—atherosclerosis	3.5e-05	0.000187	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—FABP4—atherosclerosis	3.44e-05	0.000184	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LCAT—atherosclerosis	3.44e-05	0.000184	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	3.43e-05	0.000183	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARG—atherosclerosis	3.41e-05	0.000182	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOA4—atherosclerosis	3.38e-05	0.000181	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—AKT1—atherosclerosis	3.38e-05	0.00018	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—INS—atherosclerosis	3.34e-05	0.000179	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP7A1—atherosclerosis	3.32e-05	0.000177	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	3.14e-05	0.000168	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP27A1—atherosclerosis	3.07e-05	0.000164	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALB—atherosclerosis	3.06e-05	0.000164	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.02e-05	0.000161	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NOS3—atherosclerosis	2.93e-05	0.000157	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALOX15—atherosclerosis	2.91e-05	0.000155	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALOX5AP—atherosclerosis	2.91e-05	0.000155	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLA2G2A—atherosclerosis	2.91e-05	0.000155	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOA2—atherosclerosis	2.91e-05	0.000155	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCG5—atherosclerosis	2.87e-05	0.000154	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LPA—atherosclerosis	2.77e-05	0.000148	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCG1—atherosclerosis	2.76e-05	0.000148	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	2.72e-05	0.000145	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—BGN—atherosclerosis	2.69e-05	0.000144	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—atherosclerosis	2.68e-05	0.000143	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	2.67e-05	0.000143	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOA5—atherosclerosis	2.66e-05	0.000142	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.64e-05	0.000141	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—FABP4—atherosclerosis	2.6e-05	0.000139	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LCAT—atherosclerosis	2.6e-05	0.000139	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.57e-05	0.000137	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	2.56e-05	0.000137	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA4—atherosclerosis	2.55e-05	0.000136	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP7A1—atherosclerosis	2.5e-05	0.000134	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLTP—atherosclerosis	2.48e-05	0.000133	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALOX5—atherosclerosis	2.47e-05	0.000132	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	2.47e-05	0.000132	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.37e-05	0.000127	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.34e-05	0.000125	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP27A1—atherosclerosis	2.32e-05	0.000124	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.27e-05	0.000121	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	2.27e-05	0.000121	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NAMPT—atherosclerosis	2.22e-05	0.000119	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LIPC—atherosclerosis	2.2e-05	0.000118	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALOX5AP—atherosclerosis	2.19e-05	0.000117	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLA2G2A—atherosclerosis	2.19e-05	0.000117	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA2—atherosclerosis	2.19e-05	0.000117	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALOX15—atherosclerosis	2.19e-05	0.000117	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOC3—atherosclerosis	2.19e-05	0.000117	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LDLR—atherosclerosis	2.18e-05	0.000116	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCG5—atherosclerosis	2.17e-05	0.000116	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.15e-05	0.000115	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.15e-05	0.000115	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CETP—atherosclerosis	2.13e-05	0.000114	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	2.12e-05	0.000113	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LPA—atherosclerosis	2.09e-05	0.000112	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SCARB1—atherosclerosis	2.04e-05	0.000109	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—BGN—atherosclerosis	2.03e-05	0.000108	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA5—atherosclerosis	2.01e-05	0.000107	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.93e-05	0.000103	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.92e-05	0.000103	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.91e-05	0.000102	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALOX5—atherosclerosis	1.87e-05	9.97e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.8e-05	9.6e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.71e-05	9.16e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.7e-05	9.1e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NAMPT—atherosclerosis	1.67e-05	8.95e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LIPC—atherosclerosis	1.66e-05	8.89e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOC3—atherosclerosis	1.65e-05	8.84e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LDLR—atherosclerosis	1.64e-05	8.78e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CETP—atherosclerosis	1.6e-05	8.58e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LCAT—atherosclerosis	1.6e-05	8.55e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FABP4—atherosclerosis	1.6e-05	8.55e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.58e-05	8.42e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA4—atherosclerosis	1.57e-05	8.4e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.54e-05	8.25e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SCARB1—atherosclerosis	1.54e-05	8.21e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.47e-05	7.86e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMGCR—atherosclerosis	1.45e-05	7.76e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.43e-05	7.62e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.42e-05	7.6e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOB—atherosclerosis	1.41e-05	7.53e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.37e-05	7.32e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.35e-05	7.23e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.35e-05	7.23e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA2—atherosclerosis	1.35e-05	7.23e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.35e-05	7.23e-05	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AKT1—atherosclerosis	1.35e-05	7.2e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LPL—atherosclerosis	1.35e-05	7.19e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.34e-05	7.14e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GPX1—atherosclerosis	1.31e-05	7.01e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCA1—atherosclerosis	1.29e-05	6.91e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LPA—atherosclerosis	1.29e-05	6.89e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CD36—atherosclerosis	1.28e-05	6.83e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—BGN—atherosclerosis	1.25e-05	6.68e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA5—atherosclerosis	1.24e-05	6.61e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTHFR—atherosclerosis	1.21e-05	6.47e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.19e-05	6.36e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARA—atherosclerosis	1.19e-05	6.35e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AGT—atherosclerosis	1.15e-05	6.15e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.15e-05	6.15e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOE—atherosclerosis	1.13e-05	6.03e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CAV1—atherosclerosis	1.12e-05	5.97e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOA1—atherosclerosis	1.11e-05	5.96e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMOX1—atherosclerosis	1.11e-05	5.93e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOB—atherosclerosis	1.06e-05	5.68e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTM1—atherosclerosis	1.03e-05	5.53e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.03e-05	5.51e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LIPC—atherosclerosis	1.02e-05	5.48e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOC3—atherosclerosis	1.02e-05	5.44e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CG—atherosclerosis	1.02e-05	5.44e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LPL—atherosclerosis	1.02e-05	5.43e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LDLR—atherosclerosis	1.01e-05	5.41e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPX1—atherosclerosis	9.9e-06	5.29e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CETP—atherosclerosis	9.89e-06	5.28e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARG—atherosclerosis	9.82e-06	5.25e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CD36—atherosclerosis	9.65e-06	5.15e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—INS—atherosclerosis	9.63e-06	5.15e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.47e-06	5.06e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTHFR—atherosclerosis	9.14e-06	4.88e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARA—atherosclerosis	8.97e-06	4.79e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.94e-06	4.78e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—atherosclerosis	8.83e-06	4.72e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AGT—atherosclerosis	8.68e-06	4.64e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOE—atherosclerosis	8.51e-06	4.55e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NOS3—atherosclerosis	8.45e-06	4.51e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CAV1—atherosclerosis	8.43e-06	4.51e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA1—atherosclerosis	8.41e-06	4.5e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.97e-06	4.26e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—atherosclerosis	7.73e-06	4.13e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CG—atherosclerosis	7.68e-06	4.1e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARG—atherosclerosis	7.41e-06	3.96e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—INS—atherosclerosis	7.27e-06	3.88e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.84e-06	3.65e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—atherosclerosis	6.66e-06	3.56e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOB—atherosclerosis	6.55e-06	3.5e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NOS3—atherosclerosis	6.37e-06	3.41e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.37e-06	3.41e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LPL—atherosclerosis	6.25e-06	3.34e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPX1—atherosclerosis	6.1e-06	3.26e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CD36—atherosclerosis	5.94e-06	3.18e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—atherosclerosis	5.83e-06	3.12e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.63e-06	3.01e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARA—atherosclerosis	5.52e-06	2.95e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AGT—atherosclerosis	5.35e-06	2.86e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOE—atherosclerosis	5.24e-06	2.8e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CAV1—atherosclerosis	5.19e-06	2.78e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA1—atherosclerosis	5.18e-06	2.77e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.73e-06	2.53e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARG—atherosclerosis	4.57e-06	2.44e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—INS—atherosclerosis	4.48e-06	2.39e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—atherosclerosis	4.11e-06	2.19e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NOS3—atherosclerosis	3.93e-06	2.1e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKT1—atherosclerosis	3.88e-06	2.08e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.59e-06	1.92e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKT1—atherosclerosis	2.93e-06	1.57e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKT1—atherosclerosis	1.81e-06	9.65e-06	CbGpPWpGaD
